CME and CFTC Lock Horns Over On-Chain Perpetual Futures

The dispute between the CME Group, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission (CFTC), has reached a boiling point. At the center of the controversy is the CFTC's decision to allow the listing of blockchain-based perpetual futures products, which the CME claims are being mislabeled and misregulated. The CME has filed a lawsuit against the CFTC, arguing that these products are harmful to its traditional futures contracts and that the regulator's sudden embrace of them did not consider the potential consequences. The CFTC, on the other hand, believes that its approach will foster innovation and competition in the market. The outcome of this battle will have significant implications for the US approach to the rapidly growing arena of perpetual futures, with non-US volumes reportedly reaching $60 trillion in the last year. The CME's lawsuit challenges the CFTC's decision to let the prediction markets platform Kalshi and cryptocurrency exchange Coinbase list crypto perpetual futures, which are decentralized derivative contracts that enable users to speculate on the price of an asset with leverage and no expiration date. The CME claims that these products are swaps, not futures, and therefore should be subject to different regulatory requirements. The regulator's decision to allow these products has been met with frustration and outrage from some quarters, with critics arguing that it is inappropriate for the CME to attack its own regulator. The CFTC's approach has been to undertake a case-by-case review process for perpetual futures, rather than introducing new rules that would give interested parties a chance to comment and shape the outcome. This has led to accusations that the regulator is not following proper procedures and is instead rushing to open up the US market to these products. The CME's chairman, Terry Duffy, has been vocal in his criticism of the CFTC's approach, arguing that the regulator is not prepared to enforce its emerging perps policy properly and that the products are not suitable for traditional commodities. The dispute has also highlighted the tension between traditional incumbents and new market entrants, with some arguing that the CME is using regulation to stifle competition and protect its dominance. As the legal battle unfolds, the future of CFTC-driven perpetual futures remains uncertain, with the CME preparing its case and the regulator defending its approach. The outcome will have significant implications for the development of the US market and the regulation of perpetual futures.